Skip to main content

Abecarnil: A Novel Anxiolytic with Mixed Full Agonist/Partial Agonist Properties in Animal Models of Anxiety and Sedation

  • Chapter
Anxiolytic β-Carbolines

Part of the book series: Psychopharmacology Series ((PSYCHOPHARM,volume 11))

Abstract

Although the benzodiazepines are without doubt the most effective agents currently available for the treatment of anxiety disorders, they possess a number of properties which limit their use or which give rise to problems on withdrawal. Thus, currently available benzodiazepine anxiolytics are sedative and muscle relaxant, induce memory impairment, increase the intoxicating potency of alcohol, may be subject to nontherapeutic use (abuse), and, following chronic use, may give rise to problems of dependence. For these reasons, it has been the aim of medicinal chemistry to synthesize compounds with the therapeutic strengths of the benzodiazepines, but avoiding their unwanted properties. Given the proven efficacy of anxiolytics acting at benzodiazepine receptors, an obvious approach is to seek compounds acting at this site, but which have been modified so that the unwanted properties of the benzodiazepines have been eliminated. In recent years, two approaches have been used to achieve a better dissociation of the effects of benzodiazepine-receptor ligands; the first entails the use of compounds acting at partial agonists at benzodiazepine receptors (Haefely et al. 1990), but with the discovery of a number of subtypes of y-amino- butyric acid type A (GABAA) receptors, a second approach has become feasible. Although pharmacological evidence for benzodiazepine-receptor heterogeneity has existed for some time (Corda et al. 1988; Squires et al. 1979), it is only recently that the application of molecular biological techniques to the understanding of GABAA receptors has allowed us a fuller understanding of their complexity (see Lüddens, this volume).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

eBook
USD 9.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Boissier JR, Tardy T, Diverres JC (1960) Une novelle methode simple pour explorer taction “tranquillisante”: le test de la cheminee. Med Exp 3:81–84

    CAS  Google Scholar 

  • Boissier JR, Simon P, Aron C (1969) A new method for the rapid screening of minor tranquillisers in mice. Eur J Pharmacol 4:142–150

    Google Scholar 

  • Corda MG, Giorgi O, Longoni B, Ongini E, Montaldo S, Biggio G (1988) Preferential affinity of 3H-2-oxoquazepam for type I benzodiazepine recognition sites in the human brain. Life Sci 42:189–197

    Article  PubMed  CAS  Google Scholar 

  • Crabbe J (1992) Antagonism of ethanol withdrawal convulsions in Withdrawal Seizure Prone mice by diazepam and abecarnil. Eur J Pharmacol 221:85–90

    Article  PubMed  CAS  Google Scholar 

  • Haefely W, Martin JR, Schoch P (1990) Novel anxiolytics that act as partial agonists at benzodiazepine receptors. Trends Pharmacol Sci 11:452–456

    Article  PubMed  Google Scholar 

  • Jones GH, Schneider HH, Schneider C, Stephens DN (1993) Comparison of abecarnil with other benzodiazepine-receptor ligands in two models of anxiolytic activity in the mouse: an analysis based on fractional receptor occupancies. Psychopharmacology (in press)

    Google Scholar 

  • Knoflach F, Drescher U, Scheurer L, Malherbe P, Möhler H (1993) Full and partial agonism displayed by benzodiazepine-receptor ligands at different recombinant GABAA-receptor subtypes. Mol Pharmacol (in press)

    Google Scholar 

  • Löscher W, Hönack D (1992) Withdrawal precipitation by benzodiazepine-receptor antagonists in dogs chronically treated with diazepam or the novel anxiolytic and anticonvulsant ß-carboline abecarnil. Naunyn Schmiederbergs Arch Pharmacol 345:452–460

    Google Scholar 

  • Löscher W, Hönack D, Scherkl R, Hashem A, Frey H-H (1990) Pharmacokinetics, anticonvulsant efficacy and adverse effects of the ß-carboline, abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs. J Pharmacol Exp Ther 255:541–548

    PubMed  Google Scholar 

  • Nielsen M, Braestrip C (1980) Ethyl ß-carboline-3-carboxylate shows differential benzodiazepine-receptor interaction. Nature 286:606–607

    Article  PubMed  CAS  Google Scholar 

  • Petersen EN, Jensen LH, Honore T, Braestrup C, Kehr W, Stephens DN, Wachtel H, Seidelman D, Schmiechen R (1984) ZK 91296, a partial agonist at benzodiazepine receptors. Psychopharmacology 83:240–248

    Article  PubMed  CAS  Google Scholar 

  • Pitterman W, Sontag K-H, Wand P, Rapp K, Deerberg F (1976) Spontaneous occurrence of spastic paresis in Han-Wistar rats Neurosci Lett 2:45–49

    Google Scholar 

  • Poitier MC, Prado de Carvalho L, Dodd RH, Besselievre R, Rossier J (1988) In vivo binding of ß-carbolines in mice: regional differences and correlation of occupancy to pharmacological effects. Mol Pharmacol 34:124–128

    Google Scholar 

  • Pritchett DB, Lüddens H, Seeburg PH (1989) Type I and Type II GABAA-benzodiazepine receptors produced in transfected cells. Science 245:1389–1392

    Article  PubMed  CAS  Google Scholar 

  • Squires RF, Benson DI, Braestrup C, Coupet J, Klepner CA, Myers V, Beer B (1979) Some properties of brain-specific benzodiazepine receptors: new evidence for multiple receptors. Pharmacol Biochem Behav 10:825–830

    Article  PubMed  CAS  Google Scholar 

  • Stephens DN, Schneider HH, Kehr W, Jensen LH, Petersen EN, Honore T (1987) Modulation of anxiety by ß-carbolines and other benzodiazepine-receptor ligands: relationship of pharmacological to biochemical measures of efficacy. Brain Res Bull 19:309–318

    Article  PubMed  CAS  Google Scholar 

  • Stephens DN, Schneider HH, Kehr W, Andrews JS, Rettig K-J, Turski L, Schmiechen R, Turner JD, Jensen LH, Petersen EN, Honore T, Bondo Hansen J (1990) Abecarnil, a metabolically stable, anxioselective ß-carboline acting at benzodiazepine receptors. J Pharmacol Exp Ther 253:334–343

    PubMed  CAS  Google Scholar 

  • Stephens DN, Turski L, Hillman M, Turner JD, Schneider HH, Yamaguchi M (1992) What are the differences between abecarnil and conventional benzodiazepine anxiolytics? In: Biggio G, Concas A, Costa E (eds) GABAergic synaptic transmission. Raven, New York, pp 395–405

    Google Scholar 

  • Steppuhn K, Schneider HH, Turski L, Stephens DN (1993) Long-term treatment with abecarnil does not lead to dependence in mice. J Pharmacol Exp Ther 264:1395–1400

    PubMed  CAS  Google Scholar 

  • Turski L, Stephens DN, Jensen LH, Petersen EN, Meldrum BS, Patel S, Bondo Hansen J, Löscher W, Schneider HH, Schmiechen R (1990) Anticonvulsant action of the ß- carboline, abecarnil: studies in rodents and baboon, Papio papio. J Pharmacol Exp Ther 253:344–352

    PubMed  CAS  Google Scholar 

  • Turski L, Stephens DN (1993) Effects of the ß-carboline, abecarnil, on spinal reflexes in mice, and on muscle tone in genetically spastic rats: a comparison with diazepam. J Pharmacol Exp Ther (in press)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Stephens, D.N., Turski, L., Jones, G.H., Steppuhn, K.G., Schneider, H.H. (1993). Abecarnil: A Novel Anxiolytic with Mixed Full Agonist/Partial Agonist Properties in Animal Models of Anxiety and Sedation. In: Stephens, D.N. (eds) Anxiolytic β-Carbolines. Psychopharmacology Series, vol 11. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78451-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-78451-4_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-78453-8

  • Online ISBN: 978-3-642-78451-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics